Wilms H - Search Results

1

Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils.

Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Schäfer H, Seegert D, Kahle PJ, Odoy S, Claasen JH, Holzknecht C, Brandenburg LO, Deuschl G, Schreiber S, Kirik D, Lucius R. Wilms H, et al. Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):897-909. doi: 10.1177/039463200902200405. Int J Immunopathol Pharmacol. 2009. PMID: 20074453 Free article.

2

Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease.

Wilms H, Rosenstiel P, Sievers J, Deuschl G, Zecca L, Lucius R. Wilms H, et al. FASEB J. 2003 Mar;17(3):500-2. doi: 10.1096/fj.02-0314fje. Epub 2003 Jan 21. FASEB J. 2003. PMID: 12631585

3

Regulation of activin A synthesis in microglial cells: pathophysiological implications for bacterial meningitis.

Wilms H, Schwark T, Brandenburg LO, Sievers J, Dengler R, Deuschl G, Lucius R. Wilms H, et al. J Neurosci Res. 2010 Jan;88(1):16-23. doi: 10.1002/jnr.22185. J Neurosci Res. 2010. PMID: 19681171

4

From theory to therapy: implications from an in vitro model of ramified microglia.

Rosenstiel P, Lucius R, Deuschl G, Sievers J, Wilms H. Rosenstiel P, et al. Among authors: wilms h. Microsc Res Tech. 2001 Jul 1;54(1):18-25. doi: 10.1002/jemt.1116. Microsc Res Tech. 2001. PMID: 11526952 Review.

5

Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.

Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R. Wilms H, et al. Curr Pharm Des. 2007;13(18):1925-8. doi: 10.2174/138161207780858429. Curr Pharm Des. 2007. PMID: 17584117 Review.

6

Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms.

Wilms H, Rosenstiel P, Unger T, Deuschl G, Lucius R. Wilms H, et al. Am J Cardiovasc Drugs. 2005;5(4):245-53. doi: 10.2165/00129784-200505040-00004. Am J Cardiovasc Drugs. 2005. PMID: 15984907 Review.

7

Erythropoietin does not attenuate cytokine production and inflammation in microglia--implications for the neuroprotective effect of erythropoietin in neurological diseases.

Wilms H, Schwabedissen B, Sievers J, Lucius R. Wilms H, et al. J Neuroimmunol. 2009 Jul 25;212(1-2):106-11. doi: 10.1016/j.jneuroim.2009.04.018. Epub 2009 May 22. J Neuroimmunol. 2009. PMID: 19464738

8

Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation.

Wilms H, Sievers J, Rickert U, Rostami-Yazdi M, Mrowietz U, Lucius R. Wilms H, et al. J Neuroinflammation. 2010 May 19;7:30. doi: 10.1186/1742-2094-7-30. J Neuroinflammation. 2010. PMID: 20482831 Free PMC article.

9

Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro.

Wilms H, Claasen J, Röhl C, Sievers J, Deuschl G, Lucius R. Wilms H, et al. Neurobiol Dis. 2003 Dec;14(3):417-24. doi: 10.1016/j.nbd.2003.07.002. Neurobiol Dis. 2003. PMID: 14678758

10

Clinical spectrum and physiology of palatal tremor.

Deuschl G, Wilms H. Deuschl G, et al. Among authors: wilms h. Mov Disord. 2002;17 Suppl 2:S63-6. doi: 10.1002/mds.10062. Mov Disord. 2002. PMID: 11836758 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters